Inceptionr LLC Invests in Illumina, Inc.

Got story updates? Submit your updates here. ›

Inceptionr LLC, an institutional investor, bought a new position in shares of Illumina, Inc. (NASDAQ:ILMN) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 10,917 shares of the life sciences company's stock, valued at approximately $1,037,000.

Why it matters

Illumina is a leading global life sciences company that develops and markets integrated systems for genetic analysis. The company's products are used by academic researchers, clinical laboratories, pharmaceutical and biotechnology companies, and agricultural researchers. Inceptionr LLC's investment in Illumina reflects the firm's belief in the company's growth potential and the broader trends in the life sciences industry.

The details

According to the 13F filing, Inceptionr LLC purchased 10,917 shares of Illumina, Inc. in the third quarter. Illumina is a NASDAQ-listed company that specializes in developing and marketing integrated systems for genetic analysis. The company's products are used by a wide range of customers, including academic researchers, clinical laboratories, pharmaceutical and biotechnology companies, and agricultural researchers.

• Inceptionr LLC bought the Illumina shares in the third quarter of the year.